|
 |
|
      |
|
|
» Depression
- Featured Stories - Depression Research - Recently Diagnosed » Bipolar Disorder - Featured Stories - Bipolar Disorder Research - Recently Diagnosed » Anxiety - Generalized Anxiety - Panic Disorder - Phobias - Obsessive-Compulsive Disorder - Post-Traumatic Disorder - Featured Stories - Anxiety Research - Recently Diagnosed » Childhood Disorders - Childhood Anxiety Disorder - Autism - Attention Deficit- Hyperactivity Disorder (ADHD) - Childhood Bipolar Disorder - Childhood Depression - Eating Disorders - Childhood Schizophrenia - Featured Stories - Childhood Disorders Research - Recently Diagnosed » Other Disorders » Patients & Families - Infoline - Treatment FAQ - Recommended Reading 
|
 Schizophrenia  Schizophrenia, which affects 1 percent of the world’s population, is a severe, chronic, and generally disabling brain disease. While the term schizophrenia literally means "split mind", it should not be confused with a "split", or multiple, personality. It is more accurately described as a psychosis -- a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be due to a combination of genetic and environmental factors. Symptoms of Schizophrenia The symptoms of schizophrenia fall into three main categories:
Treatments for Schizophrenia Treatment is aimed at reducing symptoms and preventing psychotic relapses and is believed to be most effective when begun early in the course of the illness. Schizophrenia is usually treated with antipsychotic medication. Once acute symptoms have lessened, a combination of medicine and psychosocial/rehabilitation interventions can be beneficial. As a chronic condition, disease management is life-long process. » NARSAD’s Role in Schizophrenia Research
Since 1987, NARSAD has provided research funds to scientists all over the world who seek the causes, treatments and eventual cures for this severe psychiatric disorder. To learn more about NARSAD-supported research on schizophrenia, click here.
» Featured Stories
Curbing Kynurenic Acid in Brain May Treat Cognitive Defects in Schizophrenia The most treatment-resistant symptoms of schizophrenia are cognitive impairments. Now, researchers from Ohio State University and the University of Maryland report they have traced the effects of elevated levels in the brain of the compound kynurenic acid to problem-solving deficits in schizophrenia. (more) |
Related News
Infoline
 |
Schizophrenia